Dr. Cabilly has served as a member of the Board of Directors since September 2009. Dr. Cabilly is a scientist and inventor in the field of immunology. He holds two landmark patents related to artificial synthesis of antibody molecules that led to the development of several commercial drugs by major biotech companies. He was co-founder Chief Scientist of Ethrog Biotechnologies Ltd., where he invented dry buffer technologies enabling the production of a disposable apparatus for gel electrophoresis containing no liquid, as well as a technology for molecular separation within small zones. In 2001, Ethrog Biotechnologies Ltd. was acquired by Invitrogen Corp. (Thermo Fisher Scientific Inc.). Dr. Cabilly serves as a director for several bio-tech companies.